This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Fujian Cosunter Pharmaceutical Co., Ltd., Medshine Discovery Inc.. Active years: 2021-2023.
Company Filing History:
1 out of 3 
1 out of 72 Years Active: 2021-2023
Title: Jinhua Du: Innovator in Hepatitis B Treatment
Introduction
Jinhua Du is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for viral hepatitis B. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from this viral infection.
Latest Patents
Among his latest patents, Jinhua Du has developed anti-HBV tetrahydroisoxazolo[4,3-c]pyridine compounds. These compounds are represented by a specific formula and include pharmaceutically acceptable salts or isomers. Additionally, he has patented hepatitis B virus surface antigen inhibitors, specifically 10-oxo-6,1-dihydrobenzo[e]pyrido[1,2-c][1,3]oxazine-9-carboxylic acid derivatives. These derivatives serve as inhibitors of hepatitis B surface antigens and can be used in the preparation of medicaments for treating viral hepatitis B.
Career Highlights
Jinhua Du has worked with notable companies in the pharmaceutical industry, including Fujian Cosunter Pharmaceutical Co., Ltd. and Medshine Discovery Inc. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in medicine.
Collaborations
Throughout his career, Jinhua Du has collaborated with talented individuals such as Fei Sun and Charles Z Ding. These partnerships have fostered a creative environment for developing new therapeutic approaches.
Conclusion
Jinhua Du's innovative work in the field of hepatitis B treatment showcases his dedication to improving healthcare outcomes. His patents reflect a commitment to advancing medical science and providing effective solutions for patients.